Description
A highly potent and selective inhibitor of the type 5 17-β-hydroxysteroid dehydrogenase AKR1C3. In repeat assays it showed an IC₅₀ of 0.013 ± 0.003 μM for AKR1C3, compared with 20.3 ± 3.8 μM against AKR1C1 and >30 μM against AKR1C2 and AKR1C4. This inhibitor also showed displays potency in a cellular assay, blocking the ability of AKR1C3 to metabolize a proven substrate. Does not display any COX (cyclooxygenase) inhibition at 10 µM in whole blood assay.
AKR1C3 inhibitor I is a highly potent and selective inhibitor of the type 5 17-β-hydroxysteroid dehydrogenase AKR1C3. In repeat assays it showed an IC₅₀ of 0.013 ± 0.003 μM for AKR1C3, compared with 20.3 ± 3.8 μM against AKR1C1 and >30 μM against AKR1C2 and AKR1C4.
2403 | AKR1C3 Inhibitor I DataSheet
Alternate Name/Synonyms: 3-(3,4-Dihydroisoquinolin2(1H)-ylsulfonyl)benzoic acid
Appearance: White solid
Formulation: N/A
CAS Number: N/A
Structure Available?: Yes
Peptide sequence: No
Salt Form: No
Molecular Formula: C₁₆H₁₅NO₄S
Molecular Weight: 317.36
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A potent and selective AKR1C3 inhibitor
MDL Number: N/A
PubChem CID: N/A
SMILES: O=S(C1=CC(C(O)=O)=CC=C1)(N2CCC(C=CC=C3)=C3C2)=O
InChi: InChI=1S/C16H15NO4S/c18-16(19)13-6-3-7-15(10-13)22(20,21)17-9-8-12-4-1-2-5-14(12)11-17/h1-7,10H,8-9,11H2,(H,18,19)
InChi Key: ZGVIUMKHTXKKOX-UHFFFAOYSA-N
Additional Information
Storage Condition: |
-20°C |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |